Fibromyalgia
973
96
120
607
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
119 trials with published results (12%)
Research Maturity
607 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.3%
32 terminated out of 973 trials
95.0%
+8.5% vs benchmark
11%
105 trials in Phase 3/4
20%
119 of 607 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 607 completed trials
Clinical Trials (973)
Effectiveness of Creatine on Pain, Fatigue, and Muscle Architectural Variables in Patients Witg Fibromyalgia.
Mandala Coloring for Pain, Fatigue, and Sleep in Patients With Fibromyalgia
High-Intensity vs. Preferred-Intensity Resistance Training in Fibromyalgia
Pain & Reward Neuromodulation of CNS Circuits
Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Self-guided Acceptance and Commitment Therapy-based Digital Smartphone Application for Management of Fibromyalgia
Effects of Box Breathing Exercise in Patients With Fibromyalgia
Assessing Central Aspects of Pain
Empowered Relief for Youth
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
Evaluation of Sound Therapy in a Population of Women With Fibromyalgia Aged Between 30 and 60 Years
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
The Role of Resilience for Physical Functioning of Patients With Fibromyalgia Syndrome Using the 6-Min Walk Test
Effects of Breathing and Attention Training (BAT) on Pain Modulation
Impact of Major Ozone Autohemotherapy on Sarcopenia Parameters in Fibromyalgia
Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial
MDMA-assisted Therapy for Fibromyalgia